These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 10759293

  • 1. Anti-atherosclerotic activity of the calcium antagonist lacidipine in cholesterol-fed hamsters.
    Cristofori P, Lanzoni A, Gaviraghi G, Turton J, Sbarbati A.
    Biomed Pharmacother; 2000 Mar; 54(2):93-9. PubMed ID: 10759293
    [Abstract] [Full Text] [Related]

  • 2. Differential effect of two calcium channel blockers--nifedipine and diltiazem--on atherogenesis in hypercholesterolemic hamster.
    Raicu M, Pojoga L, Simionescu N, Simionescu M.
    J Submicrosc Cytol Pathol; 1996 Apr; 28(2):265-75. PubMed ID: 8964051
    [Abstract] [Full Text] [Related]

  • 3. The effect of ACE inhibitors on atheroma formation is potentiated by association with a calcium channel blocker. A biochemical and ultrastructural study.
    Raicu M, Pojoga L, Simionescu N, Simionescu M.
    J Submicrosc Cytol Pathol; 1997 Jul; 29(3):317-28. PubMed ID: 9267040
    [Abstract] [Full Text] [Related]

  • 4. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M, Hosoki K, Okunishi H, Ishii K, Ikeno A, Okazaki Y.
    Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
    [Abstract] [Full Text] [Related]

  • 5. Involvement of the nitric oxide system in the anti-atherosclerotic potential of lacidipine in the ApoE-deficient mouse: a morphological, functional, and electrochemical study.
    Cristofori PG, Crivellente FA, Faustinelli I, Lanzoni AR, Lazzarini C, Vecchiato E, Andreoli M, Turton JA, Zancanaro C, Crespi FM.
    Toxicol Pathol; 2004 Mar; 32(4):493-9. PubMed ID: 15223775
    [Abstract] [Full Text] [Related]

  • 6. Effect of lercanidipine and its (R)-enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits.
    Soma MR, Natali M, Donetti E, Baetta R, Farina P, Leonardi A, Comparato C, Barberi L, Catapano AL.
    Br J Pharmacol; 1998 Dec; 125(7):1471-6. PubMed ID: 9884075
    [Abstract] [Full Text] [Related]

  • 7. The antiatherosclerotic effects of calcium antagonists.
    Paoletti R, Bernini F, Corsini A, Soma MR.
    J Cardiovasc Pharmacol; 1995 Dec; 25 Suppl 3():S6-10. PubMed ID: 8852538
    [Abstract] [Full Text] [Related]

  • 8. Effect of lacidipine on the carotid intimal hyperplasia induced by cuff injury.
    Soma MR, Donetti E, Parolini C, Barberi L, Paoletti R, Fumagalli R, Catapano AL.
    J Cardiovasc Pharmacol; 1994 Dec; 23 Suppl 5():S71-4. PubMed ID: 7609512
    [Abstract] [Full Text] [Related]

  • 9. Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster.
    Sima A, Bulla A, Simionescu N.
    J Submicrosc Cytol Pathol; 1990 Jan; 22(1):1-16. PubMed ID: 2311094
    [Abstract] [Full Text] [Related]

  • 10. Soy isoflavones prevent ovariectomy-induced atherosclerotic lesions in Golden Syrian hamster model of postmenopausal hyperlipidemia.
    Lucas EA, Lightfoot SA, Hammond LJ, Devareddy L, Khalil DA, Daggy BP, Soung do Y, Arjmandi BH.
    Menopause; 2003 Jan; 10(4):314-21. PubMed ID: 12851514
    [Abstract] [Full Text] [Related]

  • 11. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE, Perrea DN, Yatzidis HA.
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [Abstract] [Full Text] [Related]

  • 12. Antioxidant and anti-atherogenic activities of three Piper species on atherogenic diet fed hamsters.
    Agbor GA, Vinson JA, Sortino J, Johnson R.
    Exp Toxicol Pathol; 2012 May; 64(4):387-91. PubMed ID: 21035316
    [Abstract] [Full Text] [Related]

  • 13. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol.
    Kowala MC, Rose PM, Stein PD, Goller N, Recce R, Beyer S, Valentine M, Barton D, Durham SK.
    Am J Pathol; 1995 Apr; 146(4):819-26. PubMed ID: 7717449
    [Abstract] [Full Text] [Related]

  • 14. Effect of lacidipine on cholesterol esterification: in vivo and in vitro studies.
    Bernini F, Canavesi M, Bernardini E, Scurati N, Bellosta S, Fumagalli R.
    Br J Pharmacol; 1997 Nov; 122(6):1209-15. PubMed ID: 9401788
    [Abstract] [Full Text] [Related]

  • 15. Effect of VULM 1457, an ACAT inhibitor, on serum lipid levels and on real time red blood cell flow in diabetic and non-diabetic hamsters fed high cholesterol-lipid diet.
    Vojtassáková E, Syneková M, Tazká D, Mátyás S, Hózová R, Sadlonová I, Svec P.
    Gen Physiol Biophys; 2007 Dec; 26(4):254-9. PubMed ID: 18281742
    [Abstract] [Full Text] [Related]

  • 16. Chemical and physiochemical comparison of advanced atherosclerotic lesions of similar size and cholesterol content in cholesterol-fed New Zealand White and Watanabe Heritable Hyperlipidemic rabbits.
    Nolte CJ, Tercyak AM, Wu HM, Small DM.
    Lab Invest; 1990 Feb; 62(2):213-22. PubMed ID: 2304334
    [Abstract] [Full Text] [Related]

  • 17. The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis.
    Nachtigal P, Kopecky M, Solichova D, Zdansky P, Semecky V.
    J Pharm Pharmacol; 2005 Feb; 57(2):197-203. PubMed ID: 15720783
    [Abstract] [Full Text] [Related]

  • 18. Promotive effect of elastase on regression of aortic atherosclerosis in cholesterol-fed quails.
    Toda T, Hokama S, Nagamine M, Takei H.
    Exp Pathol; 1989 Feb; 36(4):201-9. PubMed ID: 2767211
    [Abstract] [Full Text] [Related]

  • 19. The impact of lacidipine, a novel dihydropyridine calcium antagonist, on carbohydrate and lipid metabolism.
    Spieker C, Zidek W.
    J Cardiovasc Pharmacol; 1995 Feb; 25 Suppl 3():S23-6. PubMed ID: 8852541
    [Abstract] [Full Text] [Related]

  • 20. The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse.
    Cristofori P, Lanzoni A, Quartaroli M, Pastorino AM, Zancanaro C, Cominacini L, Gaviraghi G, Turton J.
    J Hypertens; 2000 Oct; 18(10):1429-36. PubMed ID: 11057430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.